The relationship between the quantitative evaluation of thyroid bed uptake and the disappearance of accumulation in adjuvant radioactive iodine therapy for differentiated thyroid cancer

被引:8
|
作者
Konishi, Kenta [1 ]
Ishiba, Ryo [1 ]
Ikenohira, Tsutomu [1 ]
Asao, Tomoyuki [1 ]
Hirata, Masanori [1 ]
Ohira, Keiichi [1 ]
Komatsu, Tetsuya [1 ]
Sawada, Michifumi [2 ]
Tanahashi, Yukichi [3 ]
Goshima, Satoshi [3 ]
Magata, Yasuhiro [4 ]
Nakamura, Katsumasa [1 ]
机构
[1] Hamamatsu Univ Sch Med, Dept Radiat Oncol, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka, Japan
[2] Hamamatsu Univ Sch Med, Dept Radiol, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka, Japan
[3] Hamamatsu Univ Sch Med, Dept Diagnost Radiol & Nucl Med, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka, Japan
[4] Hamamatsu Univ Sch Med, Preeminent Med Photon Educ & Res Ctr, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka, Japan
关键词
Thyroid cancer; Radioactive iodine therapy; Adjuvant therapy; Quantitative evaluation; Absolute radioactivity concentration; CARCINOMA; ABLATION;
D O I
10.1007/s12149-020-01546-8
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective Iodine-131 (I-131) radioactive iodine therapy (RAI) after total thyroidectomy is the standard treatment for patients with differentiated thyroid cancer (DTC). We investigated the relationship between the quantitative parameters of the iodine uptake and the disappearance of the accumulation in the thyroid bed in adjuvant therapy using a 1.11 GBq or 3.70 GBq dose of I-131. Methods We retrospectively analyzed the cases of 40 patients with DTC who were treated with RAI at our institution between April 2017 and August 2019. The patients were treated with the I-131 dose of 1.11 GBq (n = 25) or 3.70 GBq (n = 15) after total thyroidectomy. The I-131 whole-body scan and hybrid single-photon emission computed tomography/X-ray computed tomography (SPECT/CT) were performed 3 days after RAI. Using image analysis software, we measured the standardized uptake value (SUV) and absolute radioactivity concentration (kBq/ml) on the target lesions with the highest uptake in the thyroid bed. Results The median period from RAI to the evaluation of the absence of uptake of the thyroid bed was 6.75 months. After RAI, uptake of the thyroid bed disappeared in 26 of the 40 patients. The disappearance rate was significantly higher in the 3.70 GBq group than in the 1.11 GBq group (86.7% vs. 52.0%, respectively; p = 0.029). However, there were no significant differences in the values of kBq/ml or SUV between the 1.11 GBq group and 3.70 GBq group. On the other hand, the group in which the uptake disappeared after RAI showed significantly higher kBq/ml max and kBq/ml mean values than the group in which the uptake did not disappear after RAI (p = 0.028, p = 0.032, respectively). The SUVmax and SUVmean also tended to be higher in the disappeared-uptake group than the not-disappeared-uptake group, but the differences were not significant (p = 0.166, p = 0.176, respectively). Conclusions The quantitative evaluation might be useful as one of the predictive indicators of the disappearance of the accumulation of radioactive iodine in the thyroid bed.
引用
收藏
页码:159 / 166
页数:8
相关论文
共 50 条
  • [31] Definition and management of radioactive iodine-refractory differentiated thyroid cancer
    Schlumberger, Martin
    Brose, Marcia
    Elisei, Rosella
    Leboulleux, Sophie
    Luster, Markus
    Pitoia, Fabian
    Pacini, Furio
    LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (05) : 356 - 358
  • [32] Current Advances in Radioactive Iodine-Refractory Differentiated Thyroid Cancer
    Volpe, Fabio
    Nappi, Carmela
    Zampella, Emilia
    Di Donna, Erica
    Maurea, Simone
    Cuocolo, Alberto
    Klain, Michele
    CURRENT ONCOLOGY, 2024, 31 (07) : 3870 - 3884
  • [33] Thyroglobulin levels before radioactive iodine therapy and dynamic risk stratification after 1 year in patients with differentiated thyroid cancer
    Bandeira, Leonardo
    Padovani, Rosalia do Prado
    Ticly, Ana Luiza
    Cury, Adriano Namo
    Scalissi, Nilza Maria
    Silveira Marone, Marilia Martins
    Ferraz, Carolina
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2017, 61 (06): : 590 - 599
  • [34] Radiotheragnostics Paradigm for Radioactive Iodine (Iodide) Management of Differentiated Thyroid Cancer
    Slonimsky, Einat
    Tulchinsky, Mark
    CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (31) : 3812 - 3827
  • [35] Tyrosine Kinase Inhibitors for Radioactive Iodine Refractory Differentiated Thyroid Cancer
    Cortas, Christos
    Charalambous, Haris
    LIFE-BASEL, 2024, 14 (01):
  • [36] Radioactive Iodine Administration Is Associated with Persistent Related Symptoms in Patients with Differentiated Thyroid Cancer
    Florenzano, Pablo
    Guarda, Francisco J.
    Jaimovich, Rodrigo
    Droppelmann, Nicolas
    Gonzalez, Hernan
    Dominguez, Jose M.
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2016, 2016
  • [37] The efficacy of radioactive iodine for the treatment of well-differentiated thyroid cancer with distant metastasis
    Lin, Jen-Der
    Kuo, Sheng-Fong
    Huang, Bie-Yui
    Lin, Shu-Fu
    Chen, Szu-Tah
    NUCLEAR MEDICINE COMMUNICATIONS, 2018, 39 (12) : 1091 - 1096
  • [38] Urinary iodine concentration and radioactive iodine therapeutic response in patients with differentiated thyroid cancer
    Jiang, Yuyan
    Jin, Jiahui
    Fan, Jingzheng
    Huang, Chao
    Jia, Qiang
    Tan, Jian
    He, Xianghui
    Zheng, Xiangqian
    Zhao, Yue
    Zhang, Qing
    Meng, Zhaowei
    Wang, Yan
    BIOMARKERS IN MEDICINE, 2021, 15 (11) : 879 - 890
  • [39] Current controversies in the initial post-surgical radioactive iodine therapy for thyroid cancer: a narrative review
    Blumhardt, Ralph
    Wolin, Ely A.
    Phillips, William T.
    Salman, Umber A.
    Walker, Ronald C.
    Stack, Brendan C., Jr.
    Metter, Darlene
    ENDOCRINE-RELATED CANCER, 2014, 21 (06) : R473 - R484
  • [40] Poorly differentiated thyroid carcinoma (PDTC) characteristics and the efficacy of radioactive iodine (RAI) therapy as an adjuvant treatment in a tertiary cancer care center
    Shivakumar Thiagarajan
    Aamir Yousuf
    Ratan Shetty
    Harsh Dhar
    Yash Mathur
    Deepa Nair
    Sandeep Basu
    Asawari Patil
    Shubadha Kane
    Sarbani Ghosh-Laskar
    Devendra Chaukar
    European Archives of Oto-Rhino-Laryngology, 2020, 277 : 1807 - 1814